Compare KOPN & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOPN | CYRX |
|---|---|---|
| Founded | 1984 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 419.3M |
| IPO Year | 2025 | 2008 |
| Metric | KOPN | CYRX |
|---|---|---|
| Price | $2.84 | $10.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $4.25 | ★ $13.31 |
| AVG Volume (30 Days) | ★ 4.0M | 393.6K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 103.03 | ★ 156.22 |
| EPS | 0.01 | ★ 1.40 |
| Revenue | $1,530,311.00 | ★ $176,177,000.00 |
| Revenue This Year | $50.07 | $11.06 |
| Revenue Next Year | $33.33 | $8.45 |
| P/E Ratio | $298.00 | ★ $7.39 |
| Revenue Growth | ★ 46.53 | N/A |
| 52 Week Low | $0.98 | $5.31 |
| 52 Week High | $4.16 | $11.45 |
| Indicator | KOPN | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 77.36 |
| Support Level | $2.24 | $9.18 |
| Resistance Level | $3.28 | $11.33 |
| Average True Range (ATR) | 0.23 | 0.41 |
| MACD | 0.05 | 0.18 |
| Stochastic Oscillator | 79.49 | 99.23 |
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.